Total arch replacement for an aortic arch aneurysm with cold agglutinin disease after rituximab and plasmapheresis

Total arch replacement for an aortic arch aneurysm with cold agglutinin disease after rituximab and plasmapheresis

Abstract Background Cold agglutinin disease can lead to significant complications, especially for patients undergoing arch repair requiring hypothermic circulatory arrest. Rituximab and plasmapheresis are treatments for cold agglutinin disease. However, its use in patients with Stanford type A disse...

Full description

Bibliographic Details
Main Authors: Atsuyuki Mitsuishi, Yujiro Miura, Kyosuke Saeki, Yoshinori Nomura, Katsumata Yoshifumi, Keisuke Yoshida
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Cold agglutinin disease
Rituximab
Plasmapheresis
Mild hypothermia
Total arch replacement
Thoracic aortic aneurysm
Online Access:https://doi.org/10.1186/s13019-023-02388-x

Internet

https://doi.org/10.1186/s13019-023-02388-x

Similar Items